Literature DB >> 14698203

Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium.

Kálmán A Kovács1, Ferenc Lengyel, József L Környei, Zsuzsanna Vértes, István Szabó, Balázs Sümegi, Marietta Vértes.   

Abstract

The expression and activation of serine/threonine protein kinase, Akt, in leiomyoma and in adjacent myometrium of human uteri was studied parallel with the changes of Bcl-2, Bax proteins, estrogen and progesterone receptors during menstrual cycle and early stage of the menopause. Abundant expression of Akt protein was detected in the studied tissues during menstrual cycle, the rate of increase was higher in leiomyoma than in corresponding myometrium. The expression of estrogen receptor alpha, progesterone receptor and of Bcl-2 protein changed parallel with that of Akt protein. The level of phosphorylated Akt (pAkt(473)) was seen only in leiomyoma samples from the growing period of tumors. At early stage of menopause levels of all studied proteins were lower than that in the menstrual cycle with the exception of Bax protein expression, which was high in leiomyoma. Our data suggest the involvement of phosphatidylinositol 3-kinase/Akt signaling in the pathomechanism of leiomyoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14698203     DOI: 10.1016/j.jsbmb.2003.09.007

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  18 in total

1.  No REST for fibroids.

Authors:  Bo R Rueda; John S Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-25       Impact factor: 11.205

Review 2.  The role of progesterone signaling in the pathogenesis of uterine leiomyoma.

Authors:  J Julie Kim; Elizabeth C Sefton
Journal:  Mol Cell Endocrinol       Date:  2011-06-06       Impact factor: 4.102

Review 3.  Recent Advances in Uterine Fibroid Etiology.

Authors:  Michelle M McWilliams; Vargheese M Chennathukuzhi
Journal:  Semin Reprod Med       Date:  2017-03-09       Impact factor: 1.303

Review 4.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

5.  MK-2206, an AKT inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth.

Authors:  Elizabeth C Sefton; Wenan Qiang; Vanida Serna; Takeshi Kurita; Jian-Jun Wei; Debabrata Chakravarti; J Julie Kim
Journal:  Endocrinology       Date:  2013-09-03       Impact factor: 4.736

6.  Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant.

Authors:  Knapp Paweł; Adrian Chabowski; Jan Górski
Journal:  Lipids       Date:  2012-12-14       Impact factor: 1.880

Review 7.  Progesterone receptor action in leiomyoma and endometrial cancer.

Authors:  J Julie Kim; Elizabeth C Sefton; Serdar E Bulun
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

8.  Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.

Authors:  Linda Yu; Katrin Saile; Carol D Swartz; Hong He; Xiaolin Zheng; Grace E Kissling; Xudong Di; Shantelle Lucas; Stanley J Robboy; Darlene Dixon
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

9.  The AKT/BCL-2 Axis Mediates Survival of Uterine Leiomyoma in a Novel 3D Spheroid Model.

Authors:  Vania Vidimar; Debabrata Chakravarti; Serdar E Bulun; Ping Yin; Romana Nowak; Jian-Jun Wei; J Julie Kim
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

10.  Inactivation of AKT induces cellular senescence in uterine leiomyoma.

Authors:  Xiaofei Xu; Zhenxiao Lu; Wenan Qiang; Vania Vidimar; Beihua Kong; J Julie Kim; Jian-Jun Wei
Journal:  Endocrinology       Date:  2014-01-29       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.